Sort

Search

24/01/2024 Immediate Partial Breast and Nipple-Areola Complex Reconstruction Using a Superficial Circumflex Iliac Artery Perforator Flap
Pons, G, Sisternas, L, Masia, J. Immediate Partial Breast and Nipple-Areola Complex Reconstruction Using a Superficial Circumflex Iliac Artery Perforator Flap. Archives Of Plastic Surgery-Aps. 2024; 51(02)DOI:10.1055/a-2223-5325. PMID:38596154. IF:(Q/D).
20/01/2024 First worldwide report on safety and efficacy of using small 7.5 Fr scope for pediatric Ureteroscopy: prospective pilot series from Europe
Jahrreiss, V, Madarriaga, YQ, Tur, AB, de Knecht, EL, Griffin, S, Somani, B. First worldwide report on safety and efficacy of using small 7.5 Fr scope for pediatric Ureteroscopy: prospective pilot series from Europe. Central European Journal Of Urology. 2024; 77(1)DOI:10.5173/ceju.2023.248. PMID:38645818. IF:(Q/D).
20/01/2024 Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry
Molina-Collada, J, Domínguez-Alvaro, M, Melero-González, RB, Fernández-Fernández, E, Silva-Díaz, M, Valero, JA, González, I, Martín, JS, Narváez, J, Calvo, I, Mendizábal, J, Alcázar, LA, Loricera, J, Ruíz-Román, A, Moya, P, Cabañas, MT, Estrada, P, Prado-Galbarro, FJ, Castañeda, S, Blanco, R. Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry. RHEUMATOLOGY. 2024; DOI:10.1093/rheumatology/keae042. PMID:38244610. IF:4.400(Q1/1D).
20/01/2024 Health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) treated with sotorasib and panitumumab (pmab) versus trifluridine/tipiracil (T/T) or regorafenib (rego) in CodeBreaK 300.
Modest, DP, Fakih, M, Salvatore, L, Esaki, T, Lopez-Bravo, DP, Taieb, J, Karamouzis, M, Ruiz-Garcia, E, Kim, TW, Kuboki, Y, Meriggi, F, Cunningham, D, Yeh, KH, Cremolini, C, Tran, Q, Chan, E, Chao, J, Majer, IM, Pietrantonio, F. Health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) treated with sotorasib and panitumumab (pmab) versus trifluridine/tipiracil (T/T) or regorafenib (rego) in CodeBreaK 300.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(3_SUPPL)DOI:10.1200/JCO.2024.42.3_suppl.10. PMID:. IF:41.900(Q1/1D).